Ribosomal protein L39 pseudogene 29 (RPL39P29)

RPL39P29 (ribosomal protein L39 pseudogene 29) is a processed pseudogene derived from the RPL39 gene, which encodes a component of the large ribosomal 60S subunit involved in protein synthesis[1][3][4][6]. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically do not encode active proteins due to mutations, truncations, or regulatory defects[1]. RPL39P29 does not produce a functional protein and is not associated with biological functions, disease roles, drug interactions, or therapeutic mechanisms. It is not considered a therapeutic target or biomarker and is classified as "Other" under molecular classifications due to its pseudogene status. No evidence links RPL39P29 directly to disease or clinical implications. Annotation notes: - *is_incorrect:true*: The query asked about a “molecule/receptor”—RPL39P29 is neither a receptor, enzyme, transporter, nor a therapeutic target, and does not encode a functional protein[1][6]. - Most information available applies to the parent gene RPL39, not the pseudogene RPL39P29 itself[1][3][4]. No evidence suggests RPL39P29 functions in cellular or disease processes, and it is not associated with drug targeting or biomarker utility. - The related RPL39 gene encodes a ribosomal protein involved in protein synthesis, but the pseudogene does not share these properties[3][4]. If you require information on the functional parent gene RPL39, details are available regarding its role in ribosome structure, protein synthesis, and disease associations[3][4], but these do not apply to RPL39P29.

Other names

RPL39_15_1333